Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrustpilot Regulatory News (TRST)

Share Price Information for Trustpilot (TRST)

Share Price is delayed by 15 minutes
Get Live Data
254.00    4.20 (1.68%)
Bid:
256.20
Ask:
256.80
Spread: 0.60 (0.234%)
Market Cap: £982.28m
TRST Live PriceLast checked at - London Stock Exchange

Intraday Trustpilot Share Chart

Stabilisation Notice

7 Sep 2021 17:52

RNS Number : 0371L
Morgan Stanley & Co. Int'l plc
07 September 2021
 

2021/09/07

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Trustpilot Group plc

Post-Stabilisation Notice

Morgan Stanley & Co. International plc (contact: James Cresswell; telephone: +44 (0)20 7677 0981) hereby gives notice that it undertook stabilisation (within the meaning of Article 3(2)(d) of Regulation (EU) 596/2014, including as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018)) in relation to the offer of the following securities, as set out below.

Issuer

Trustpilot Group plc

ISIN

GB00BNK9TP58

Description

Ordinary registered shares ("ORDs" or "Ordinary Shares") of the Issuer

Stabilisation Manager(s)

Morgan Stanley & Co. International plc, 25 Cabot Square, Canary Wharf, London E14 4QA

Offer Price

265 pence per Offer Share

Offer Size

178,596,461 Ordinary Shares (excluding the over-allotment option)

Stabilisation Started

2021/03/23

Stabilisation Last Occurred

2021/04/06

Price Range of Stabilisation Trades

GBP 2.5000 - GBP 2.6500

Stabilisation Trading Venue

London Stock Exchange multilateral trading facility MTF (XLOM); London Stock Exchange (XLON); Turquoise Lit Auctions (TRQA); Turquoise (TRQX); Turquoise Plato (TRQM); CBOE Europe - CXE Dark Order Book (CHID); POSIT Dark (XPOS); Morgan Stanley and Co. International PLC - Systematic Internaliser (MSSI); Morgan Stanley and Co. International Plc (MSIP)

 

 

For each of the dates during which stabilisation transactions were carried out, the price range was as follows:

 

 

 

 

Date

Lowest Price

(GBP)

Highest Price

(GBP)

Trading Venue

2021/03/23

2.6500

2.6500

XLOM

2021/03/24

2.5000

2.6500

XLOM, MSIP, MSSI

2021/03/25

2.5560

2.6500

XLOM, MSIP

2021/03/26

2.6200

2.6500

XLON

2021/03/29

2.5808

2.6500

XLON, XPOS, TRQX, TRQM

2021/03/30

2.6000

2.6500

XLON, XPOS, TRQX, TRQA

2021/03/31

2.6270

2.6500

XLON, XPOS, TRQX, TRQM, CHID, MSIP

2021/04/01

2.6340

2.6500

XLON, TRQX

2021/04/06

2.6500

2.6500

XLON

 

For details of the options granted by certain of the selling shareholders to the underwriters (so called Greenshoe Option) please refer to the notice dated 16 April 2021: https://www.investegate.co.uk/trustpilot-group-plc/rns/exercise-of-over-allotment-option/202104161739337979V/ 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, the UK before the publication of a prospectus in relation to the securities which has been approved by the competent authority in the UK in accordance with Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (the "UK Prospectus Regulation"), this announcement and the offer are only addressed to and directed at persons in the UK who are qualified investors within the meaning of the UK Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in the UK.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with Regulation (EU) 2017/1129 (the "EEA Prospectus Regulation") (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the EEA Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in Member State who are qualified investors within the meaning of the EEA Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States.

END.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STALRMFTMTIMBLB
Date   Source Headline
1st Jun 20267:26 amRNSTransaction in Own Shares
29th May 20261:53 pmRNSTotal Voting Rights
26th May 20267:34 amRNSTransaction in Own Shares
19th May 20264:41 pmRNSResult of AGM
19th May 20261:00 pmRNSCEO’s Comments at the 2026 Annual General Meeting
18th May 20267:00 amRNSTransaction in Own Shares
13th May 20269:34 amRNSHolding(s) in Company
12th May 20266:17 pmRNSHolding(s) in Company
11th May 20267:59 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTrust Capital Markets Event
5th May 202611:17 amRNSTransaction in Own Shares
1st May 20265:01 pmRNSHolding(s) in Company
30th Apr 20262:03 pmRNSTotal Voting Rights
27th Apr 202611:47 amRNSTrustpilot to host Trust education event
27th Apr 20267:28 amRNSTransaction in Own Shares
24th Apr 202610:16 amRNSHolding(s) in Company
23rd Apr 20262:31 pmRNSDirector/PDMR Shareholding
22nd Apr 202611:07 amRNSDirector Declaration
21st Apr 20267:00 amRNSAppointment of Non-Executive Director
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20264:38 pmRNS2025 Annual Report and Notice of 2026 AGM
13th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20264:23 pmRNSDirector/PDMR Shareholding
7th Apr 20268:31 amRNSDirector/PDMR Shareholding
7th Apr 20268:14 amRNSTransaction in Own Shares
31st Mar 20264:56 pmRNSTotal Voting Rights
30th Mar 20268:27 amRNSTransaction in Own Shares
27th Mar 20264:13 pmRNSBlock Admission Application
26th Mar 20264:10 pmRNSDirector/PDMR Shareholding
25th Mar 20267:05 amRNSCompletion of share buyback programme
24th Mar 20263:54 pmRNSDirector/PDMR Shareholding
24th Mar 20263:45 pmRNSHolding(s) in Company
24th Mar 20267:00 amRNSAppointment of Marcus Roy as CFO
24th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSResults of secondary placing in Trustpilot
23rd Mar 20262:03 pmRNSTrustpilot to appeal AGCM finding
20th Mar 202611:20 amRNSHolding(s) in Company
19th Mar 20263:19 pmRNSDirector/PDMR Shareholding
19th Mar 20262:59 pmRNSHolding(s) in Company
17th Mar 20267:00 amRNSShare Buyback Programme
17th Mar 20267:00 amRNSShare Buyback Programme
17th Mar 20267:00 amRNSProfitability ahead of expectations
17th Mar 20267:00 amRNSProfitability ahead of expectations
16th Mar 20263:09 pmRNSHolding(s) in Company
16th Mar 20263:09 pmRNSHolding(s) in Company
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.